NEWSWIRETODAY Press Release & Newswire Distribution | HOME
MOST TRUSTED NEWSWIRE PRESS RELEASE DISTRIBUTION
PRTODAY / NewswireToday press release distribution service network
Agency / Source: CHUSEI (USA), Inc.

Check Ads Availability|e-mail Article

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Phyto-Source, L.P. Updates Phytosterol Capacity Expansion - Phyto-Source, L.P., one of the world's leading suppliers of high purity, non-GMO wood (plant) derived sterols, has made significant progress in increasing capacity at their manufacturing facility in Houston, Texas - ChuseiUSA.com
Phyto-Source, L.P. Updates Phytosterol Capacity Expansion

 

NewswireTODAY - /newswire/ - Pasadena, TX, United States, 2007/06/07 - Phyto-Source, L.P., one of the world's leading suppliers of high purity, non-GMO wood (plant) derived sterols, has made significant progress in increasing capacity at their manufacturing facility in Houston, Texas - ChuseiUSA.com.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma / BioTech / Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

In January, 2007, Phyto-Source’s plant capacity was successfully increased by over forty percent to meet the increased demand for the company’s cholesterol-lowering food ingredient, Phyto-S-Sterol™. Further process debottlenecking initiatives, technology improvements, and capital additions have resulted in an additional thirty percent capacity increase. The plant’s total output is now 3000 MT per year.

Bill Sonnier, President and CEO of Chusei (USA) and Manager of Phyto-Source, notes that “this recent expansion of our ability to produce high quality phytosterols is our second step in our goal to significantly increase our production volume and capabilities. There will be further expansion of capacity and product varieties at our Houston facility in the near term. We are also moving forward with plans to build a major manufacturing plant in Europe so that we can better serve that market’s growing need for phytosterols.”

Sonnier went on to say “Phyto-Source is well positioned to meet the requirements for new applications and customers in the sterol marketplace. The global market for phytosterols is expanding and Phyto-Source is prepared for this development through the application of is proprietary, state-of-the-art technology. By expanding our capacity in Houston and building new capacity in Europe, Phyto-Source will continue to build its leadership position”

Phyto-Source, L.P. (phytosourcelp.com) is a leading producer of high-quality non-Genetically Modified (non-GM) wood (plant) sterols and serves a growing list of customers around the world.

Chusei (U.S.A.) Inc. (chuseiusa.com) serves the custom chemical manufacturing industry through its manufacturing facility located in the Houston, Texas area. Chusei also serves as the operating partner for Phyto-Source, L.P.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma / BioTech / Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Agency / Source: CHUSEI (USA), Inc.

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick NewswireToday Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma / BioTech / Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


Phyto-Source, L.P. Updates Phytosterol Capacity Expansion

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name NewswireToday and LINK as the source.
 
  For more information, please visit:
Is this your article? Activate ALL web links by Upgrading to Press Release PREMIUM Plan Now!
|
Contact: Thomas Stegmann - PhytoSourceLP.com 
281-291-7990 x18 tom.stegmann[.]phytosourcelp.com
 
PRZOOM / PRTODAY - Newswire Today disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any CHUSEI (USA), Inc. securities in any jurisdiction including any other companies listed or named in this release.

Pharma / BioTech / Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!


Read Latest Articles From CHUSEI (USA), Inc. / Company Profile


Read Pharma / BioTech / Nutrition Most Recent Related Newswires:

Ono Commences Research Collaboration with Jorna Therapeutics to Generate Novel RNA Editing Therapeutics
SCHOTT Pharma Opens Production Facility in Serbia to Strengthen Competitiveness in Europe
NEC Has Developed Technologies that Enable A Secure Workflow for Personalized Cancer Vaccines and Has Proven their Capabilities
BASF Aroma Ingredients Innovates with Two New Isobionics® Biotech Flavor Ingredients
Federal Government Invests .9 Million in STEMCELL Technologies Canada, Inc.
Ono Enters into License Agreement with Ionis Pharmaceuticals for Sapablursen for the Treatment of Polycythemia Vera
Boehringer Ingelheim Partners with Veeva to Launch ‘One Medicine Platform’
U.S. FDA Grants Full Approval of Deciphera’s ROMVIMZA™ (vimseltinib) for the Treatment of Symptomatic Tenosynovial Giant Cell Tumor (TGCT)
U.S. Food and Drug Administration Approves Opdivo Qvantig™ (nivolumab & hyaluronidase-nvhy) Injection
NEC Announces Interim Results from Phase 1 Clinical Trial of NECVAX-NEO1
SCHOTT Pharma Unveils Innovative Nest Design for Ready-to-use Cartridges
Ipsen and Biomunex Announce Exclusive Global Licensing Agreement for First-in-class MAIT Cell Engager in Immuno-oncology
Bushu Pharma Applauded by Frost & Sullivan for Offering Customer Value in APAC CDMO Industry through Consistent Quality Assurance, On-time Delivery
Bylvay® (odevixibat) Data Shows Sustained Improvement in Severe Itch and Serum Bile Acid Levels in Patients with PFIC and ALGS
Genome BC, STEMCELL Technologies and UBC Partner to Accelerate the Ability to Develop Stem Cells

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
NewswireToday Celebrates 10 Years in Business


PREMIUM Members


Visit  Limelon Advertising, Co.

Visit  RightITnow, Inc.





 
  ©2005-2025 NewswireToday — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution prtoday.com newswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
 
PRTODAY & NewswireTODAY are proudly NOT affiliated with USA TODAY (usatoday.com)